Drug Search Results

Velafermin

Alternative Names: velafermin, CG53135-05
Latest Update: 2023-01-27
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: CuraGen
Company Location: NEEDHAM MA 02494
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Velafermin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Mucositis|Stomatitis

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
CG53135-CLN-12	P2	Completed	Mucositis\|Stomatitis	2008-08-01
C-421	P2	Completed	Stomatitis\|Mucositis	2005-12-01

Recent News Events

Date	Type	Title
01/27/2023	PubMed	FGF20 and PGM2 variants are associated with childhood asthma in family-based whole-genome sequencing studies.
05/01/2022	PubMed	Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.
04/01/2022	PubMed	MiR-1226, mediated by ASCL1, suppresses the progression of non-small cell lung cancer by targeting FGF2.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions